Loading clinical trials...
Loading clinical trials...
Prospective, randomized multicenter study to determine the safety and effectiveness of performing corneal collagen cross-linking (CXL) using riboflavin and UVA light in eyes with ectasia after refract...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Glaukos Corporation
NCT06306963 · Gastric Antral Vascular Ectasia, Cirrhosis, and more
NCT07414446 · Hereditary Haemorrhagic Telangiectasia, PFO - Patent Foramen Ovale, and more
NCT06573723 · Rare Diseases, Amyloidosis, and more
NCT02118922 · Keratoconus, Ectasia, and more
NCT03030755 · Cornea; Ectasia, Refractive Errors, and more
Shiley Eye Center
La Jolla, California
Gordon -Weiss Vision Institute
San Diego, California
Center for Excellence in Eye Care
Miami, Florida
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions